However, extended ADT often leads to prostate cancer recurrence, marked by increased prostate-specific antigen (PSA) levels and the emergence of castration-resistant prostate cancer (CRPC), which adversely affects prognosis [3]. The gene discussed is PLAG1; the disease is prostate cancer.